CAOVY yields 4.65% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, CAOVY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CAOVY + JNJ for your $10,000?
China Overseas Land & Investment Limited, an investment holding company, engages in the property development and investment, and other operations in the People's Republic of China and the United Kingdom. The company operates through Property Development, Property Investment, and Other Operations segments. It is involved in the investment, development, and rental of residential and commercial properties; issuance of guaranteed notes and corporate bonds; and hotel operation activities. The company also provides construction and building design consultancy services. In addition, it engages in the investment and financing, land consolidation, regional planning, engineering construction, industrial import, commercial operation, and property management. Further, the company offers urban services, including office buildings, flexible working space, shopping malls, star-rated hotels, long-term rental apartments, logistics parks, and architectural design and construction. The company was founded in 1979 and is based in Central, Hong Kong. China Overseas Land & Investment Limited is a subsidiary of China Overseas Holdings Limited.
Full CAOVY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.